Literature DB >> 1889086

Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.

S Fleury1, D Lamarre, S Meloche, S E Ryu, C Cantin, W A Hendrickson, R P Sekaly.   

Abstract

Using functional and adhesion assays, we have studied the ability of 30 human CD4 mutants to interact with class II major histocompatibility complex (MHC) molecules and also with gp120 from human immunodeficiency virus. The mutants cover the four domains (D1-D4) of CD4 and include several single-site substitutions. Analysis of the results, in the context of the CD4 crystal structure, shows that mutations that affect the interaction with class II MHC molecules are located on three exposed loops from CD4 domains 1 and 2. The specifically implicated residues, 19, 89, and 165, are separated from one another by 9 A, 24 A, and 24 A on one face of the CD4 molecule. Moreover, the class II binding site does not include residues 43 to 49 of the CD4 molecule, a region on an opposite face known to be involved in the binding of gp120.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889086     DOI: 10.1016/0092-8674(91)90447-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  35 in total

1.  Identification of a ligand-binding site in an immunoglobulin fold domain of the Saccharomyces cerevisiae adhesion protein alpha-agglutinin.

Authors:  H de Nobel; P N Lipke; J Kurjan
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

2.  Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.

Authors:  S Moir; J Perreault; L Poulin
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 3.  CD4 on the road to coreceptor status.

Authors:  Dario A A Vignali
Journal:  J Immunol       Date:  2010-06-01       Impact factor: 5.422

Review 4.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

5.  Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding.

Authors:  U Moebius; P Pallai; S C Harrison; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 6.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.

Authors:  J F Zagury; J Bernard; A Achour; A Astgen; A Lachgar; L Fall; C Carelli; W Issing; J P Mbika; O Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry.

Authors:  S Malhotra; A G Scott; T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model.

Authors:  P A Giblin; D J Leahy; J Mennone; P B Kavathas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.